Requirement for antigen processing and influence of invariant chain and H-2M deficiencies on T-Cell activation in autoimmune encephalomyelitis

Requirement for antigen processing and influence of invariant chain and H-2M deficiencies on T-Cell activation in autoimmune encephalomyelitis

Bibliographic Details
Main Authors:	Slavin, A, Soos, J, Stuve, O, Patarroyo, J, Weiner, H, Fontana, A, Bikoff, E, Zamvil, S
Format:	Journal article
Published:	2001

Similar Items

Influence of invariant chain and H-2M deficiencies in antigen processing and T cell activation in autoimmune encephalomyelitis.
by: Slavin, A, et al.
Published: (2000)

Requirement for endocytic antigen processing and influence of invariant chain and H-2M deficiencies in CNS autoimmunity.
by: Slavin, A, et al.
Published: (2001)

K+ channel alterations in the progression of experimental autoimmune encephalomyelitis
by: Peter I. Jukkola, et al.
Published: (2012-08-01)

Presenilin1 regulates Th1 and Th17 effector responses but is not required for experimental autoimmune encephalomyelitis.
by: Matthew Cummings, et al.
Published: (2018-01-01)

Deficiency of Antigen Presenting Cell Invariant Chain Reduces Atherosclerosis in Mice
by: Ploegh, Hidde, et al.
Published: (2012)

Astrocytes express elements of the class II endocytic pathway and process central nervous system autoantigen for presentation to encephalitogenic T cells.
by: Soos, J, et al.
Published: (1998)

Delayed onset of experimental autoimmune encephalomyelitis in Olig1 deficient mice.
by: Xiaoli Guo, et al.
Published: (2010-01-01)

Experimental autoimmune encephalomyelitis
by: Jean Kanellopoulos
Published: (2015-06-01)

P2x7 deficiency suppresses development of experimental autoimmune encephalomyelitis
by: Lin Shao X, et al.
Published: (2008-08-01)

Major histocompatibility class II peptide occupancy, antigen presentation, and CD4+ T cell function in mice lacking the p41 isoform of invariant chain.
by: Takaesu, N, et al.
Published: (1995)

Codelivery of antigen and an immune cell adhesion inhibitor is necessary for efficacy of soluble antigen arrays in experimental autoimmune encephalomyelitis
by: Joshua O Sestak, et al.
Published: (2014-01-01)

Interleukin-19 Abrogates Experimental Autoimmune Encephalomyelitis by Attenuating Antigen-Presenting Cell Activation
by: Hiroshi Horiuchi, et al.
Published: (2021-03-01)

Amelioration of experimental autoimmune encephalomyelitis by anatabine.
by: Daniel Paris, et al.
Published: (2013-01-01)

Optimal attenuation of experimental autoimmune encephalomyelitis by intravenous immunoglobulin requires an intact interleukin-11 receptor.
by: Carlyn A Figueiredo, et al.
Published: (2014-01-01)

Tolerogenic Lipid Nanoparticles for Delivering Self-Antigen mRNA for the Treatment of Experimental Autoimmune Encephalomyelitis
by: Masaki Gomi, et al.
Published: (2023-09-01)

Dysregulation of lysophosphatidic acids in multiple sclerosis and autoimmune encephalomyelitis
by: K. Schmitz, et al.
Published: (2017-06-01)

Bi-Allelic TCRα or β Recombination Enhances T Cell Development but Is Dispensable for Antigen Responses and Experimental Autoimmune Encephalomyelitis.
by: Nathaniel J Schuldt, et al.
Published: (2015-01-01)

Peptide immunotherapy in experimental autoimmune encephalomyelitis
by: Stephen M Anderton
Published: (2015-06-01)

Lymph node-derived donor encephalitogenic CD4<sup>+ </sup>T cells in C57BL/6 mice adoptive transfer experimental autoimmune encephalomyelitis highly express GM-CSF and T-bet
by: Lambracht-Washington Doris, et al.
Published: (2011-06-01)

Loss of invariant chain protects nonobese diabetic mice against type 1 diabetes.
by: Mellanby, R, et al.
Published: (2006)

Protoporphyrin Treatment Modulates Susceptibility to Experimental Autoimmune Encephalomyelitis in miR-155-Deficient Mice.
by: Jinyu Zhang, et al.
Published: (2015-01-01)

Allelic differences affecting invariant chain dependency of MHC class II subunit assembly.
by: Bikoff, E, et al.
Published: (1995)

Comparison of thymocyte development in normal and invariant chain-deficient mice provides evidence that maturation-related changes in TCR and co-receptor levels play a critical role in cell fate.
by: Huang, L, et al.
Published: (1996)

Monitoring retinal changes with optical coherence tomography predicts neuronal loss in experimental autoimmune encephalomyelitis
by: Andrés Cruz-Herranz, et al.
Published: (2019-11-01)

Interferon Lambda Signaling Restrains Experimental Autoimmune Encephalomyelitis
by: Mohammad Asif Sherwani, et al.
Published: (2024-02-01)

Nogo-receptor 1 deficiency has no influence on immune cell repertoire or function during experimental autoimmune encephalomyelitis.
by: Sara A Litwak, et al.
Published: (2013-01-01)

Reducing suffering in experimental autoimmune encephalomyelitis (EAE).
by: Wolfensohn, S, et al.
Published: (2013)

Behavioral investigation of mice with experimental autoimmune encephalomyelitis
by: David Henrique Rodrigues, et al.
Published: (2011-12-01)

Therapeutic potential of agmatine in the experimental autoimmune encephalomyelitis
by: Stevanović Ivana, et al.
Published: (2021-01-01)

Contribution of pannexin1 to experimental autoimmune encephalomyelitis.
by: Sarah E Lutz, et al.
Published: (2013-01-01)

Exercise training alters autoimmune cell invasion into the brain in autoimmune encephalomyelitis
by: Liel Hamdi, et al.
Published: (2022-11-01)

Rituximab therapy reduces organ-specific T cell responses and ameliorates experimental autoimmune encephalomyelitis.
by: Nancy L Monson, et al.
Published: (2011-02-01)

Dissecting MHC class II export, B cell maturation, and DM stability defects in invariant chain mutant mice.
by: Koonce, C, et al.
Published: (2004)

In vivo functions mediated by the p41 isoform of the MHC class II-associated invariant chain.
by: Takaesu, N, et al.
Published: (1997)

Correction: Optimal Attenuation of Experimental Autoimmune Encephalomyelitis by Intravenous Immunoglobulin Requires an Intact Interleukin-11 Receptor
Published: (2014-01-01)

Correction: Optimal Attenuation of Experimental Autoimmune Encephalomyelitis by Intravenous Immunoglobulin Requires an Intact Interleukin-11 Receptor.
Published: (2014-01-01)

Abrogation of Endogenous Glycolipid Antigen Presentation on Myelin-Laden Macrophages by D-Sphingosine Ameliorates the Pathogenesis of Experimental Autoimmune Encephalomyelitis
by: Yi Ban, et al.
Published: (2019-03-01)

Modulation of experimental autoimmune encephalomyelitis by endogenous Annexin A1
by: Flower Rod J, et al.
Published: (2009-11-01)

Fetuin-A deficiency protects mice from Experimental Autoimmune Encephalomyelitis (EAE) and correlates with altered innate immune response.
by: Violaine K Harris, et al.
Published: (2017-01-01)

Connexin 30 Deficiency Attenuates Chronic but Not Acute Phases of Experimental Autoimmune Encephalomyelitis Through Induction of Neuroprotective Microglia
by: Mei Fang, et al.
Published: (2018-11-01)